Cohort study for children's AIDS treatment reduction program

Major national science and technology projects - special projects for the prevention and treatment of major infectious diseases, including AIDS and viral hepatitis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900024605

Enrollment

Unknown

Registered

2019-07-18

Start date

2019-08-01

Completion date

Unknown

Last updated

2019-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AIDS

Interventions

Experimental group:EFV is reducted to 400mg

control group:no

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. aged 10-19 year old; 2. AZT/D4T+3TC+NVP/EFV, ART>=1year 3. HIV-RNA<400copies/ml; 4. well tolerated with the ART regimen being used and no opportunistic infection.

Exclusion criteria

Exclusion criteria: no

Design outcomes

Primary

Measure	Time frame
HIV-RNA;CD4T-cell;HIV-1 resistance test;Blood routine;Blood chemistry;	—

Countries

China

Contacts

Public ContactZhang Fujie

Beijing Ditan Hospital affiliated to Capital Medical University

treatment@chinaaids.cn+86 13001953958

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026